Author:
Chiang Joen,Chan Alexandre,Shih Vivianne,Hee Siew Wan,Tao Miriam,Lim Soon Thye
Publisher
Springer Science and Business Media LLC
Reference9 articles.
1. National Comprehensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology. Non-Hodgkin’s Lymphomas. Version 1.2010.
2. Rituximab (Rituxan). South San Francisco: Genetech Inc. 2008.
3. Salar A, Casao D, Cervera M, Pedro C, Calafell M, Abella E, et al. Rapid infusion of rituximab with or without steroid-containing chemotherapy: 1-yr experience in a single institution. Eur J Haematol. 2006;77(4):338–40.
4. Sehn LH, Donaldson J, Filewich A, Fitzgerald C, Gill KK, Runzer N, et al. Rapid infusion rituximab in combination with corticosteroid-containing chemotherapy or as maintenance therapy is well tolerated and can safely be delivered in the community setting. Blood. 2007;109(10):4171–3.
5. Gibbs S, Pout G, Wimperis J. Rapid infusion rituximab is as effective and safe as conventional infusion regimes in the treatment of diffuse large B cell lymphoma: a 2 year prospective study. Haematologica. 2007;92(Suppl. 2):264.
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献